argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/30/2026

1. META
2. MSFT
3. V
4. SPY
5. PYPL
6. KLAC
7. BE
8. STX
9. CSGP
10. SWKS

Go back to argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
(NASDAQ: FBRX) Delayed: 76.53 --0 (-0%)
Previous Close $76.53    52 Week High $ 
Open $76.53    52 Week Low $ 
Day High $76.53    P/E N/A 
Day Low $76.53    EPS $ 
Volume 256